{"DataElement":{"publicId":"2801171","version":"1","preferredName":"Clinical Study Protocol Salvage Therapy Agent Administered Type","preferredDefinition":"the type of protocol-defined salvage treatment being administered.","longName":"PROT_STX_AGT_ADM_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2801169","version":"1","preferredName":"Clinical Study Protocol Salvage Therapy Agent Administered","preferredDefinition":"information relating to the protocol-defined administration of salvage therapy (treatment that is given after the cancer has not responded to other treatments).","longName":"PROT_SLVGTX_AGT_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2801167","version":"1","preferredName":"Clinical Study Protocol Salvage Therapy Agent","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.:Treatment that is given after the cancer has not responded to other treatments.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C25320:C15359:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Salvage Therapy","conceptCode":"C15359","definition":"Performing a salvage procedure is the last resort. The clinical situation involves either ongoing life support measures, life support measures for more than 60 seconds during the prior 10 minutes, or unanticipated institution of extracorporeal circulatory support. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE467A9-8C37-3635-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-17","modifiedBy":"ONEDATA","dateModified":"2008-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE46C6D-711A-37A5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2801170","version":"1","preferredName":"Salvage Therapy Administered Type","preferredDefinition":"the type of salvage therapy administered.","longName":"SLVGTX_ADMIN_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Bevacizumab alone","valueDescription":"Bevacizumab alone","ValueMeaning":{"publicId":"2569366","version":"1","preferredName":"Bevacizumab alone","longName":"2569366","preferredDefinition":"Bevacizumab alone","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC03-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE3885F-751F-3824-E044-0003BA3F9857","beginDate":"2008-11-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-17","modifiedBy":"ONEDATA","dateModified":"2008-11-17","deletedIndicator":"No"},{"value":"Bevacizumab and Irinotecan","valueDescription":"Bevacizumab and Irinotecan","ValueMeaning":{"publicId":"2800764","version":"1","preferredName":"Bevacizumab and Irinotecan","longName":"2800764","preferredDefinition":"Bevacizumab and Irinotecan","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BA8DEB0-83B9-6486-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE3885F-752A-3824-E044-0003BA3F9857","beginDate":"2008-11-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-17","modifiedBy":"ONEDATA","dateModified":"2008-11-17","deletedIndicator":"No"},{"value":"Bevacizumab and TMZ salvage","valueDescription":"Bevacizumab and TMZ salvage","ValueMeaning":{"publicId":"2800765","version":"1","preferredName":"Bevacizumab and TMZ salvage","longName":"2800765","preferredDefinition":"Bevacizumab and TMZ salvage","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BA8E0FE-806B-71EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE3885F-7535-3824-E044-0003BA3F9857","beginDate":"2008-11-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-17","modifiedBy":"ONEDATA","dateModified":"2008-11-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE47DBC-E21E-39AA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-17","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Salvage treatment being repor","type":"Preferred Question Text","description":"Salvage treatment being reported","url":null,"context":"CTEP"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5BE47ED6-6B4B-39DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-11-17","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}